P216 Impact of Tachycardia and New Onset Atrial Fibrillation in Acute Exacerbations of COPD: Abstract P216 Table 1

Short, PM; Chalmers, JD; Akram, AR; Schembri, Stuart; Williamson, Peter

doi:10.1136/thoraxjnl-2012-202678.277

Cited by 6 publications

(9 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Inter-rater reliability was strong ( κ , 0.80). Of the 20 included studies, 13 studies used retrospective cohort designs ( Alves Guimaraes et al, 2018 ; Chen & Liao, 2018a ; Desai et al, 2019 ; Ganga et al, 2013 ; Genao et al, 2015 ; Hu & Lin, 2018 ; Koskela et al, 2014 ; Lainscak et al, 2009 ; Liao & Chen, 2017 ; Rusinowicz, Zielonka & Zycinska, 2017 ; Wang et al, 2018b ; Warnier et al, 2010 ; Xiao et al, 2019 ), three were prospective cohorts ( Hirayama et al, 2018 ; Short et al, 2012 ; Volchkova et al, 2015 ), three were case-control studies ( Celli et al, 2010 ; Nadeem et al, 2015 ; Tomioka et al, 2019 ), and one was a prospective nested case-control study ( Wilchesky et al, 2012 ). All studies examined new-onset AF in patients with COPD.…”

Section: Resultsmentioning

confidence: 99%

“…As shown in Table 1 , the methodological quality of the observational studies was rated high, with 10 studies scoring nine of nine on the NOS ( Alves Guimaraes et al, 2018 ; Celli et al, 2010 ; Chen & Liao, 2018a ; Desai et al, 2019 ; Genao et al, 2015 ; Short et al, 2012 ; Tomioka et al, 2019 ; Wang et al, 2018b ; Warnier et al, 2010 ; Xiao et al, 2019 ), six scoring eight of nine ( Hirayama et al, 2018 ; Hu & Lin, 2018 ; Koskela et al, 2014 ; Lainscak et al, 2009 ; Nadeem et al, 2015 ; Volchkova et al, 2015 ), three scoring seven of nine ( Ganga et al, 2013 ; Liao & Chen, 2017 ; Wilchesky et al, 2012 ), and one scoring six of nine ( Rusinowicz, Zielonka & Zycinska, 2017 ). The overall risk of bias was rated low; however, the included studies used different disease definitions, which influenced the population selection.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Risk factors for new-onset atrial fibrillation in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

Huang

Xiong

Shuai

et al. 2020

PeerJ

View full text Add to dashboard Cite

Background New-onset atrial fibrillation (AF) in patients with chronic obstructive pulmonary disease (COPD) is associated with an accelerated decline in lung function, and a significant increase in mortality rate. A deeper understanding of the risk factors for new-onset AF during COPD will provide insights into the relationship between COPD and AF and guide clinical practice. This systematic review and meta-analysis is designed to identify risk factors for new-onset AF in patients with COPD, and to formulate recommendations for preventing AF in COPD patients that will assist clinical decision making. Methods PubMed, Embase, Web of Science and Cochrane Library databases were searched for studies, which reported the results of potential risk factors for new-onset AF in COPD patients. Results Twenty studies involving 8,072,043 participants were included. Fifty factors were examined as potential risk factors for new-onset AF during COPD. Risk factors were grouped according to demographics, comorbid conditions, and COPD- and cardiovascular-related factors. In quantitative analysis, cardiovascular- and demographic-related factors with a greater than 50% increase in the odds of new-onset AF included age (over 65 years and over 75 years), acute care encounter, coronary artery disease, heart failure and congestive heart failure. Only one factor is related to the reduction of odds by more than 33.3%, which is black race (vs white). In qualitative analysis, the comparison of the risk factors was conducted between COPD-associated AF and non-COPD-associated AF. Cardiovascular-related factors for non-COPD-associated AF were also considered as risk factors for new-onset AF during COPD; however, the influence tended to be stronger during COPD. In addition, comorbid factors identified in non-COPD-associated AF were not associated with an increased risk of AF during COPD. Conclusions New-onset AF in COPD has significant demographic characteristics. Older age (over 65 years), males and white race are at higher risk of developing AF. COPD patients with a history of cardiovascular disease should be carefully monitored for new-onset of AF, and appropriate preventive measures should be implemented. Even patients with mild COPD are at high risk of new-onset AF. This study shows that risk factors for new-onset AF during COPD are mainly those associated with the cardiovascular-related event and are not synonymous with comorbid factors for non-COPD-associated AF. The pathogenesis of COPD-associated AF may be predominantly related to the cardiac dysfunction caused by the chronic duration of COPD, which increases the risk of cardiovascular-related factors and further increases the risk of AF during COPD. PROSPERO registration number CRD42019137758.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Risk factors for new-onset atrial fibrillation in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

Huang

Xiong

Shuai

et al. 2020

PeerJ

View full text Add to dashboard Cite

show abstract

“…Inter-rater reliability was strong (ĸ, 0.80). Of the 20 included studies, 13 studies used retrospective cohort designs (Alves Guimaraes et al 2018;Chen & Liao 2018;Desai et al 2019;Ganga et al 2013;Genao et al 2015;Hu & Lin 2018;Koskela et al 2014;Lainscak et al 2009;Liao & Chen 2017;Rusinowicz et al 2017;Wang et al 2018b;Warnier et al 2010;Xiao et al 2019a), three were prospective cohorts (Hirayama et al 2018;Short et al 2012;Volchkova et al 2015), three were case-control studies (Celli et al 2010;Nadeem et al 2015;Tomioka et al 2019), and one was a prospective nested case-control study (Wilchesky et al 2012). All studies examined new-onset AF in patients with COPD.…”

Section: Study Selection and Study Characteristicsmentioning

confidence: 99%

“…Alves Guimaraes et al 2018;Celli et al 2010;Chen & Liao 2018a;Desai et al 2019;Genao et al 2015;Short et al 2012;Tomioka et al 2019; Wang et al 2018b;Warnier et al 2010; Xiao et al 2019b), six scoring eight of nine(Hirayama et al 2018;Hu & Lin 2018;Koskela et al 2014;Lainscak et al 2009;Nadeem et al 2015;Volchkova et al 2015), three scoring seven of nine(Ganga et al 2013;Liao & Chen 2017;Wilchesky et al 2012), and one scoring six of nine(Rusinowicz et al 2017). The overall risk of PeerJ reviewing PDF | (2020:02:46024:4:0:NEW 3 Oct 2020)…”

mentioning

confidence: 99%

Peer Review #3 of "Risk factors for new-onset atrial fibrillation in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis (v0.3)"

Gray¹

2020

View full text Add to dashboard Cite

“…Left ventricular hypertrophy is harmful because it preempts so many different cardiac sequelae, for example LVH is arrhythmogenic, it reduces coronary perfusion reserve, it prevents LV filling, and thereby causes diastolic heart failure and it leads to LA dilatation, atrial fibrillation, and cardioembolic strokes [9]. The clinical relevance of these factors is demonstrated in COPD patients with increased mortality reported in those with a history of atrial fibrillation or increased resting heart rate [10][11][12].…”

Section: Introductionmentioning

confidence: 97%

Impact of Left Ventricular Hypertrophy on Survival in Chronic Obstructive Pulmonary Disease

Short

Anderson

Elder

et al. 2015

Lung

View full text Add to dashboard Cite

show abstract

P216 Impact of Tachycardia and New Onset Atrial Fibrillation in Acute Exacerbations of COPD: Abstract P216 Table 1

Cited by 6 publications

References 0 publications

Risk factors for new-onset atrial fibrillation in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

Risk factors for new-onset atrial fibrillation in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

Peer Review #3 of "Risk factors for new-onset atrial fibrillation in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis (v0.3)"

Impact of Left Ventricular Hypertrophy on Survival in Chronic Obstructive Pulmonary Disease

Contact Info

Product

Resources

About